IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 192 filers reported holding IMMUNOGEN INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | +100.0% | 1,807 | +103.5% | 0.00% | +100.0% |
| Q1 2019 | $2,000 | -33.3% | 888 | +59.7% | 0.00% | -50.0% |
| Q4 2018 | $3,000 | -40.0% | 556 | +8.8% | 0.00% | 0.0% |
| Q3 2018 | $5,000 | -16.7% | 511 | -16.0% | 0.00% | -33.3% |
| Q2 2018 | $6,000 | -14.3% | 608 | -13.4% | 0.00% | 0.0% |
| Q1 2018 | $7,000 | +16.7% | 702 | -6.4% | 0.00% | 0.0% |
| Q4 2017 | $6,000 | -50.0% | 750 | -51.2% | 0.00% | -50.0% |
| Q3 2017 | $12,000 | -14.3% | 1,536 | -26.5% | 0.01% | -14.3% |
| Q2 2017 | $14,000 | +40.0% | 2,090 | -11.0% | 0.01% | +40.0% |
| Q1 2017 | $10,000 | +25.0% | 2,348 | -41.7% | 0.01% | 0.0% |
| Q4 2016 | $8,000 | – | 4,026 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |